MedTrace Logo

Coronary Artery Calcium Score in HIV Mexican Population (The CACsHIVMex Study)

NCT07662161 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 384

Last updated 2026-06-23

No results posted yet for this study

Summary

The risk of atherosclerotic cardiovascular disease is increased in people with HIV infection, including young patients and those with few traditional cardiovascular risk factors. The increased risk of cardiovascular disease among people living with HIV is due to accelerated atherosclerosis, caused by chronic inflammation and immune dysregulation. The measurement of coronary calcium using plain computed tomography is a subclinical indicator of coronary atherosclerosis and is associated with the risk of cardiovascular events and mortality in the general population.

Conditions

  • HIV - Human Immunodeficiency Virus

Interventions

DIAGNOSTIC_TEST

Simple coronary CT scan

All patients will undergo a standard coronary CT scan to measure coronary calcium

Sponsors & Collaborators

  • Instituto Mexicano del Seguro Social

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2026-12-30
Completion
2030-07-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07662161 on ClinicalTrials.gov